EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antigenicity of key hepatitis C virus E1E2 glycoprotein neutralizing sites is genotype independent

Jessica L Mimms, Ariadne Sinnis-Bourozikas, Nathaniel R Felbinger, Nicole Frumento, Harry T Paul, Arvind H Patel, Zhenyong Keck, Steven K H Foung, Mansun Law, Richard A Urbanowicz, Alexander W Tarr, Jonathan K Ball und 2 weitere

Journal of General Virology · 2026

DOI: 10.1099/jgv.0.002201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of General Virology, 2026. Verfasst von Jessica L Mimms und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Hauptthemen laut MEDLINE: Hepacivirus, Viral Envelope Proteins, Antibodies, Neutralizing, Hepatitis C Antibodies. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of an effective prophylactic hepatitis C virus (HCV) vaccine is a priority to achieve global elimination of the virus. Accurate assessment of the neutralizing breadth of antibodies induced by vaccines and a clear understanding of the antigenic differences between viral variants included in vaccines are both critical for vaccine development. Prior studies have indicated that HCV genotypes (gts) do not dictate the sensitivity of HCV envelope glycoprotein (E1E2) variants to neutralizing antibodies. However, most of these prior studies under-sampled variants from gts 2–6. Here, we selected a genetically diverse and representative panel of gt 2–6 E1E2 variants, used them to generate HCV pseudoparticles (HCVpp), and measured neutralization of these HCVpp by neutralizing antibodies and HCV-immune plasma from persons infected with gt 1–6 viruses. We found that neutralization results obtained with this gt 2–6 panel were remarkably similar to results obtained with a previously described, antigenically diverse, gt 1-predominant reference panel of 15 HCVpp. These data confirm that, even considering genetically diverse HCV variants across gt 1–6, E1E2 antigenicity is not dictated by gt, and that the previously published panel of 15 HCVpp represents neutralization of all HCV gts with reasonable accuracy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HepacivirusViral Envelope ProteinsAntibodies, NeutralizingHepatitis C AntibodiesHumansGenotypeHepatitis CNeutralization Tests

Stichwörter der Autor:innen

hepatitis C virus (HCV)hepatitis C virus (HCV) vaccinehepatitis C virus pseudoparticles (HCVpp)neutralizing antibodyneutralizing breadth

Substanzen

Viral Envelope ProteinsAntibodies, NeutralizingHepatitis C Antibodiesglycoprotein E2, Hepatitis C virusE1 protein, Hepatitis C virus

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • University of Maryland Institute for Bioscience and Biotechnology Research, Rockville, MD, USA.
  • Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, MD, USA.
  • Peter Medawar Building for Pathogen Research, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
  • MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
  • CVR-CRUSH, MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.

Förderung

  • NIAID NIH HHS
  • NIH

Zitieren

APA

Mimms, J. L., Sinnis-Bourozikas, A., Felbinger, N. R., Frumento, N., Paul, H. T., Patel, A. H., Keck, Z., Foung, S. K. H., Law, M., Urbanowicz, R. A., Tarr, A. W., Ball, J. K., Pierce, B. G., & Bailey, J. R. (2026). Antigenicity of key hepatitis C virus E1E2 glycoprotein neutralizing sites is genotype independent. Journal of General Virology. https://doi.org/10.1099/jgv.0.002201

Vancouver

Mimms JL, Sinnis-Bourozikas A, Felbinger NR, Frumento N, Paul HT, Patel AH, et al. Antigenicity of key hepatitis C virus E1E2 glycoprotein neutralizing sites is genotype independent. Journal of General Virology. 2026. doi:10.1099/jgv.0.002201

BibTeX
@article{Mimms2026,
  author = {Mimms, Jessica L and Sinnis-Bourozikas, Ariadne and Felbinger, Nathaniel R and Frumento, Nicole and Paul, Harry T and Patel, Arvind H and Keck, Zhenyong and Foung, Steven K H and Law, Mansun and Urbanowicz, Richard A and Tarr, Alexander W and Ball, Jonathan K and Pierce, Brian G and Bailey, Justin R},
  title = {Antigenicity of key hepatitis C virus E1E2 glycoprotein neutralizing sites is genotype independent},
  journal = {Journal of General Virology},
  year = {2026},
  doi = {10.1099/jgv.0.002201}
}
Kostenlos starten →